Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jordan R. Richards
Institution:
University of Iowa
Observed institutions:
University of Iowa,
University of Iowa Hospitals and Clinics
ORCID:
0000-0001-5140-9111
Observed ORCID:
0000-0001-5140-9111
OpenAlex ID:
A5062735043
Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder Cancer
2025
·
Vignesh T. Packiam
, Ian M. McElree
, et al.
·
European Urology Oncology
·
20
Oncologic Outcomes of Bladder-sparing Management for High-grade Non-invasive Urothelial Carcinoma of the Prostatic Urethra
2024
·
Alexander C. Martin
, Ian M. McElree
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
2
Pd12-10 an Artificial Intelligence-powered Predictive Biomarker for Response to Intravesical Bcg Versus Gemcitabine-docetaxel for High-grade Non-muscle Invasive Bladder Cancer
2025
·
Vignesh Packiam
, Ian M. Mcelree
, et al.
·
The Journal of Urology
PDF
Recurrent heterotopic ossification following open radical nephrectomy
2023
·
Jordan R. Richards
, Ian M. McElree
, et al.
·
Urology Case Reports
Pd14-05 Long-term Follow-up of Intravesical Gemcitabine and Docetaxel as Rescue Therapy for Non-muscle Invasive Bladder Cancer
2022
·
Phani T. Chevuru
, Ian M. McElree
, et al.
·
The Journal of Urology
Show more works
View as search
Works count:
5
Citation count:
22
H-index:
2
I10-index:
1
Year
Topic
Type